# RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)

> **NCT06935578** · — · RECRUITING · sponsor: **Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta** · enrollment: 500 (estimated)

## Conditions studied

- CADASIL
- CADASIL (Diagnosis)
- Moya Moya Disease
- Moyamoya
- Moyamoya Syndrome
- Sneddon Syndrome
- Fabry Disease
- COL4A1\2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06935578
- **Lead sponsor:** Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-01
- **Primary completion:** 2026-05-19
- **Final completion:** 2026-05-19
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06935578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06935578, "RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)". Retrieved via AI Analytics 2026-07-30 from https://api.ai-analytics.org/clinical/NCT06935578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*